A Massachusetts man is the only one in the country who has tried a nasal spray treatment for Alzheimer's. He's going to help ...

The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...

Mumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has ...

Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.

Milestone Pharmaceuticals (MIST) announced that it has received Notice of Allowance from the United States Patent and Trademark Office, or ...

Almost 100,000 bottles of nasal spray were recalled for a "microbial failure" that led to multiple complaints from customers.

The kits include two Narcan nasal spray devices with instructions for the proper administration and steps to be taken in the ...

The FDA is already limited in policing claims of health benefits by makers of supplements and herbal remedies — a $70 billion ...

Milestone’s NDA for CARDAMYST is currently under review at the FDA with a Prescription Drug User Fee Act (PDUFA) target date of March 27, 2025. The Company continues to advance commercial preparations ...

The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA ...

Letters to the editors for the November 2024 issue of Scientific American ...

After the rejection of Lykos Therapeutics’ MDMA-based PTSD treatment tempered excitement for psychedelic therapeutics, a ...